Vivek Samnotra MD

Assistant Professor, Medicine, Geisel School of Medicine

99 Lincoln StFramingham, MA 01702
Phone+1 508-383-8510
Fax+1 508-383-8584

Dr. Samnotra is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Samnotra's full profile Already have an account?

Education & Training

St Elizabeth's Medical CenterResidency, Internal Medicine, 1991 - 1993
UPMC Medical EducationInternship, Internal Medicine, 1989 - 1990
McGill University Faculty of MedicineClass of 1989

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MA State Medical License 1993 - 2027
TX State Medical License 1997 - 2024
WY State Medical License 1997 - 2023
NH State Medical License 2001 - 2021
FL State Medical License 1996 - 2000
PA State Medical License 1996 - 2000
WV State Medical License 1997 - 1997

Clinical Trials

Phase II Trial of ZD1839 (Iressa) in Patients With Nonresectable Adrenocortical Carcinoma (ACC)
COMPLETED
PHASE2
Treatment Study Using Bevacizumab for Patients With Adrenocortical Carcinoma
WITHDRAWN
PHASE2

Publications & Presentations

PubMed

13 citations
Niraparib, Dostarlimab, and Bevacizumab as Combination Therapy in Pretreated, Advanced Platinum-Resistant Ovarian Cancer: Findings From Cohort A of the OPAL Phase II T...
Joyce F Liu, Stéphanie Gaillard, Andrea E Wahner Hendrickson, Oladapo Yeku, Elisabeth Diver
JCO Precision Oncology. 2024-05-01
21 citations
Niraparib and dostarlimab for the treatment of recurrent platinum-resistant ovarian cancer: results of a Phase II study (MOONSTONE/GOG-3032).
Leslie M Randall, David M O'Malley, Bradley J Monk, Robert L Coleman, Stephanie Gaillard
Gynecologic Oncology. 2023-11-01
3 citations
Effect of Pevonedistat, an Investigational NEDD8-Activating Enzyme Inhibitor, on the QTc Interval in Patients With Advanced Solid Tumors.
Xiaofei Zhou, Debra L Richardson, Afshin Dowlati, Sanjay Goel, Solmaz Sahebjam
Clinical Pharmacology in Drug Development. 2023-03-01